blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2533804

EP2533804 - ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 161P2F10B PROTEINS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  15.02.2019
Database last updated on 07.10.2024
FormerThe patent has been granted
Status updated on  09.03.2018
FormerGrant of patent is intended
Status updated on  19.09.2017
FormerExamination is in progress
Status updated on  07.08.2017
FormerGrant of patent is intended
Status updated on  03.04.2017
FormerExamination is in progress
Status updated on  22.02.2017
FormerGrant of patent is intended
Status updated on  11.12.2016
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
Agensys, Inc.
1800 Stewart Street
Santa Monica, CA 90404 / US
[2017/16]
Former [2012/51]For all designated states
Agensys, Inc.
2225 Colorado Boulevard
Santa Monica, CA 90404 / US
Inventor(s)01 / TORGOV, Michael
2914 Arizona Avenue, Apt 3
Santa Monica, CA 90404 / US
02 / MORRISON, Robert, Kendall
1044 Yale Street
Santa Monica, CA 90403 / US
03 / JAKOBOVITS, Aya
3135 Hutton Drive
Beverly Hills, CA 90210 / US
04 / GUDAS, Jean
13340 Chalon Road
Los Angeles, CA 90049 / US
05 / AN, Zili
2914 Arizona Avenue, Apt. No. 3
Santa Monica, CA 90404 / US
 [2017/13]
Former [2012/51]01 / TORGOV, Michael
2914 Arizona Avenue, Apt 3
Santa Monica, CA 90404 / US
02 / MORRISON, Robert, Kendall
1044 Yale Street
Santa Monica, CA 90403 / US
03 / JAKOBOVITS, Aya
3135 Hutton Drive
Beverly Hills, CA 90210 / US
04 / GUDAS, Jean
13340 Chalon Road
Los Angeles, CA 90049 / US
05 / AN, Zili
2225 Colorado Avenue
Santa Monica, CA 90404 / US
Representative(s)Bezzubova, Olga, et al
Jones Day
Prinzregentenstraße 11
80538 München / DE
[2018/15]
Former [2012/51]Höglund, Lars
Albihns.Zacco AB
P.O. Box 5581
114 85 Stockholm / SE
Application number, filing date11740529.008.02.2011
[2018/15]
WO2011US24055
Priority number, dateUS20100302489P08.02.2010         Original published format: US 302489 P
[2012/51]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2011097627
Date:11.08.2011
Language:EN
[2011/32]
Type: A1 Application with search report 
No.:EP2533804
Date:19.12.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 11.08.2011 takes the place of the publication of the European patent application.
[2012/51]
Type: B1 Patent specification 
No.:EP2533804
Date:11.04.2018
Language:EN
[2018/15]
Search report(s)International search report - published on:US11.08.2011
(Supplementary) European search report - dispatched on:EP15.10.2013
ClassificationIPC:A61K47/68, C07K16/28, A61K39/395, C07K16/30, A61K39/00
[2017/39]
CPC:
A61K47/6811 (EP,US); A61K39/395 (KR); C07K16/28 (EP,CN,US);
A61K47/42 (KR); A61K47/50 (KR); A61K47/6849 (EP,US);
A61K47/6861 (EP,US); A61P1/16 (EP); A61P13/12 (EP);
A61P35/00 (EP); C07K16/3038 (EP,CN,US); A61K2039/505 (EP,CN,US);
A61K39/39558 (EP,CN,US); C07K2317/21 (EP,CN,US); C07K2317/56 (US);
C07K2317/92 (EP,CN,US) (-)
Former IPC [2017/15]A61K39/00, A61K39/395, C07K16/00, C07K16/28, C07K16/30, A61K47/55
Former IPC [2013/46]A61K39/00, A61K47/48, A61K39/395, C07K16/00, C07K16/28, C07K16/30
Former IPC [2012/51]A61K39/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2012/51]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:AN 161P2F10B-PROTEINE BINDENDE ANTIKÖRPER-WIRKSTOFFKONJUGATE (ADC)[2012/51]
English:ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 161P2F10B PROTEINS[2012/51]
French:CONJUGUÉS ANTICORPS-MÉDICAMENTS (ADC) QUI SE LIENT AUX PROTÉINES 161P2F10B[2012/51]
Entry into regional phase03.09.2012National basic fee paid 
03.09.2012Search fee paid 
03.09.2012Designation fee(s) paid 
03.09.2012Examination fee paid 
Examination procedure03.09.2012Examination requested  [2012/51]
06.05.2014Amendment by applicant (claims and/or description)
25.06.2015Despatch of a communication from the examining division (Time limit: M04)
22.10.2015Reply to a communication from the examining division
08.12.2015Communication of intention to grant the patent
08.04.2016Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
27.06.2016Communication of intention to grant the patent
12.12.2016Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
17.02.2017Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
04.04.2017Communication of intention to grant the patent
28.07.2017Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
20.09.2017Communication of intention to grant the patent
19.01.2018Fee for grant paid
19.01.2018Fee for publishing/printing paid
19.01.2018Receipt of the translation of the claim(s)
Divisional application(s)EP18162821.5  / EP3395361
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  25.06.2015
Opposition(s)14.01.2019No opposition filed within time limit [2019/12]
Request for further processing for:The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent
17.02.2017Request for further processing filed
17.02.2017Full payment received (date of receipt of payment)
Request granted
01.03.2017Decision despatched
Fees paidRenewal fee
27.02.2013Renewal fee patent year 03
27.02.2014Renewal fee patent year 04
26.02.2015Renewal fee patent year 05
26.02.2016Renewal fee patent year 06
27.02.2017Renewal fee patent year 07
27.02.2018Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU08.02.2011
AL11.04.2018
AT11.04.2018
CY11.04.2018
CZ11.04.2018
DK11.04.2018
EE11.04.2018
FI11.04.2018
HR11.04.2018
LT11.04.2018
LV11.04.2018
MK11.04.2018
NL11.04.2018
PL11.04.2018
RO11.04.2018
RS11.04.2018
SE11.04.2018
SI11.04.2018
SK11.04.2018
SM11.04.2018
TR11.04.2018
BG11.07.2018
NO11.07.2018
GR12.07.2018
IS11.08.2018
PT13.08.2018
[2022/31]
Former [2021/32]HU08.02.2011
AL11.04.2018
AT11.04.2018
CY11.04.2018
CZ11.04.2018
DK11.04.2018
EE11.04.2018
FI11.04.2018
HR11.04.2018
LT11.04.2018
LV11.04.2018
NL11.04.2018
PL11.04.2018
RO11.04.2018
RS11.04.2018
SE11.04.2018
SI11.04.2018
SK11.04.2018
SM11.04.2018
TR11.04.2018
BG11.07.2018
NO11.07.2018
GR12.07.2018
IS11.08.2018
PT13.08.2018
Former [2021/31]AL11.04.2018
AT11.04.2018
CY11.04.2018
CZ11.04.2018
DK11.04.2018
EE11.04.2018
FI11.04.2018
HR11.04.2018
LT11.04.2018
LV11.04.2018
NL11.04.2018
PL11.04.2018
RO11.04.2018
RS11.04.2018
SE11.04.2018
SI11.04.2018
SK11.04.2018
SM11.04.2018
TR11.04.2018
BG11.07.2018
NO11.07.2018
GR12.07.2018
IS11.08.2018
PT13.08.2018
Former [2021/26]AL11.04.2018
AT11.04.2018
CY11.04.2018
CZ11.04.2018
DK11.04.2018
EE11.04.2018
FI11.04.2018
HR11.04.2018
LT11.04.2018
LV11.04.2018
NL11.04.2018
PL11.04.2018
RO11.04.2018
RS11.04.2018
SE11.04.2018
SI11.04.2018
SK11.04.2018
SM11.04.2018
TR11.04.2018
BG11.07.2018
NO11.07.2018
GR12.07.2018
PT13.08.2018
Former [2020/16]AL11.04.2018
AT11.04.2018
CZ11.04.2018
DK11.04.2018
EE11.04.2018
FI11.04.2018
HR11.04.2018
LT11.04.2018
LV11.04.2018
NL11.04.2018
PL11.04.2018
RO11.04.2018
RS11.04.2018
SE11.04.2018
SI11.04.2018
SK11.04.2018
SM11.04.2018
TR11.04.2018
BG11.07.2018
NO11.07.2018
GR12.07.2018
PT13.08.2018
Former [2019/26]AL11.04.2018
AT11.04.2018
CZ11.04.2018
DK11.04.2018
EE11.04.2018
FI11.04.2018
HR11.04.2018
LT11.04.2018
LV11.04.2018
NL11.04.2018
PL11.04.2018
RO11.04.2018
RS11.04.2018
SE11.04.2018
SI11.04.2018
SK11.04.2018
SM11.04.2018
BG11.07.2018
NO11.07.2018
GR12.07.2018
PT13.08.2018
Former [2019/12]AL11.04.2018
AT11.04.2018
CZ11.04.2018
DK11.04.2018
EE11.04.2018
FI11.04.2018
HR11.04.2018
LT11.04.2018
LV11.04.2018
NL11.04.2018
PL11.04.2018
RO11.04.2018
RS11.04.2018
SE11.04.2018
SK11.04.2018
SM11.04.2018
BG11.07.2018
NO11.07.2018
GR12.07.2018
PT13.08.2018
Former [2019/10]AL11.04.2018
AT11.04.2018
CZ11.04.2018
DK11.04.2018
EE11.04.2018
FI11.04.2018
HR11.04.2018
LT11.04.2018
LV11.04.2018
NL11.04.2018
PL11.04.2018
RO11.04.2018
RS11.04.2018
SE11.04.2018
SK11.04.2018
BG11.07.2018
NO11.07.2018
GR12.07.2018
PT13.08.2018
Former [2019/09]AL11.04.2018
DK11.04.2018
EE11.04.2018
FI11.04.2018
HR11.04.2018
LT11.04.2018
LV11.04.2018
NL11.04.2018
PL11.04.2018
RS11.04.2018
SE11.04.2018
BG11.07.2018
NO11.07.2018
GR12.07.2018
PT13.08.2018
Former [2019/08]AL11.04.2018
DK11.04.2018
FI11.04.2018
HR11.04.2018
LT11.04.2018
LV11.04.2018
NL11.04.2018
PL11.04.2018
RS11.04.2018
SE11.04.2018
BG11.07.2018
NO11.07.2018
GR12.07.2018
PT13.08.2018
Former [2019/03]AL11.04.2018
FI11.04.2018
HR11.04.2018
LT11.04.2018
LV11.04.2018
NL11.04.2018
PL11.04.2018
RS11.04.2018
SE11.04.2018
BG11.07.2018
NO11.07.2018
GR12.07.2018
PT13.08.2018
Former [2018/52]AL11.04.2018
FI11.04.2018
HR11.04.2018
LT11.04.2018
LV11.04.2018
NL11.04.2018
PL11.04.2018
RS11.04.2018
SE11.04.2018
BG11.07.2018
NO11.07.2018
GR12.07.2018
Former [2018/51]AL11.04.2018
FI11.04.2018
HR11.04.2018
LT11.04.2018
LV11.04.2018
NL11.04.2018
PL11.04.2018
RS11.04.2018
SE11.04.2018
BG11.07.2018
NO11.07.2018
Former [2018/50]AL11.04.2018
FI11.04.2018
HR11.04.2018
LT11.04.2018
NL11.04.2018
PL11.04.2018
SE11.04.2018
BG11.07.2018
NO11.07.2018
Former [2018/49]AL11.04.2018
FI11.04.2018
LT11.04.2018
NL11.04.2018
PL11.04.2018
SE11.04.2018
BG11.07.2018
NO11.07.2018
Former [2018/47]AL11.04.2018
FI11.04.2018
LT11.04.2018
NL11.04.2018
NO11.07.2018
Former [2018/46]AL11.04.2018
LT11.04.2018
NL11.04.2018
NO11.07.2018
Former [2018/43]NL11.04.2018
Documents cited:Search[Y]WO03040340  (AGENSYS INC [US], et al) [Y] 1-12 * page 4, paragraph 4 - page 6, paragraph 4 * * page 16, paragraph 2 *;
 [Y]WO2006105488  (AGENSYS INC [US], et al) [Y] 1-12 * paragraphs [0001] , [0028] , [0030] , [0115] , [0284] , [0607]; claims 7,18 *;
 [Y]WO2008100805  (GENENTECH INC [US], et al) [Y] 1-12* paragraphs [0009] , [0011]; claims 10,20 *;
 [Y]  - SVETLANA O. DORONINA ET AL, "Enhanced Activity of Monomethylauristatin F through Monoclonal Antibody Delivery: Effects of Linker Technology on Efficacy and Toxicity", BIOCONJUGATE CHEMISTRY, (20060101), vol. 17, no. 1, doi:10.1021/bc0502917, ISSN 1043-1802, pages 114 - 124, XP055009264 [Y] 1-12 * abstract * * page 115, column l, paragraph 2 * * figure 1 * * Discussion *

DOI:   http://dx.doi.org/10.1021/bc0502917
International search[Y]US2003206905  (JAKOBOVITS AYA [US], et al);
 [Y]US2006233794  (LAW CHE-LEUNG [US], et al);
 [Y]US2006275211  (JAKOBOVITS AYA [US], et al)
by applicantUS3817837
 US3850752
 US3939350
 US3996345
 US4275149
 US4277437
 US4366241
 US4486414
 US4676980
 US4816567
 US4816444
 US4879278
 US4880935
 WO9007861
 US4970198
 US4975278
 US4978744
 US4986988
 US5076973
 US5079233
 US5122368
 US5138036
 US5410024
 US5504191
 US5521284
 US5530097
 US5545806
 US5554725
 US5569825
 US5585089
 US5599902
 US5606040
 US5622929
 US5624821
 US5625126
 US5633425
 US5635483
 US5648260
 US5661016
 US5663149
 US5665860
 US5677425
 US5693762
 US5739116
 WO9816628
 US5767285
 US5773001
 US5780588
 US5824805
 US5869046
 WO9958572
 US6034065
 US6107540
 US6121022
 US6130237
 US6165745
 US6194551
 US6214345
 US6239104
 US6277375
 US6323315
 WO0243478
 WO02088172
 US2003083263
 WO03040340
 US6657103
 WO2004010957
 EP1391213
 US2005009751
 WO2005092380
 US2005238649
 US2006024317
 WO2006034488
 US2006074008
 US7067130
 WO2006105488
 US7226594
 US7279556
 US7405290
 WO2008100805
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.